STREFEN

This brand name is authorized in Spain, Finland, France, Israel, Lithuania, United Kingdom

Active ingredients

The drug STREFEN contains one active pharmaceutical ingredient (API):

1 Flurbiprofen UNII 5GRO578KLP - FLURBIPROFEN

Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties. Read about Flurbiprofen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STREFEN HONEY AND LEMON Lozenge	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R02AX01		R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AX Other throat preparations
Discover more medicines within R02AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 72938, 76902, 79428
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 451795, 481045, 579833
Country: FR	Base de données publique des médicaments	Identifier(s): 66007465, 67845628
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 37561
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 5538, 7025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1087013, 1092806